LND topic: drug-policy-commission page 1

drug policy commission

Graduate fights back against US visa crackdown over pro-Palestinian views

April 18, 2026

A young academic from Turkey who completed her doctorate in the US has packed her bags and gone home after months of legal battles. Rumeysa Ozturk was studying child development at Tufts University when her student visa mysteriously vanished without explanation. No crime was committed, no new policy

education

Kansas Parks That Tell America’s Story

April 18, 2026

Kansas quietly guards some of the nation’s most meaningful places, where grasslands roar, forts stand frozen in time, and a single courtroom changed the course of schooling forever. Five spots across the state fall under the National Park Service, each with a different heartbeat. Four lean into huma

health

How Machine Learning is Helping Fight Drug-Resistant TB in Egypt

April 18, 2026

For over ten years, doctors in Egypt have been tracking how patients respond to tuberculosis treatment. Tuberculosis, a lung infection spread through the air, has always been hard to treat. But a bigger problem is growing: some TB strains no longer respond to standard medicines. These drug-resistant

politics

Republican Candidates for Oregon Governor Focus on State Issues in Pre-Primary Debate

April 18, 2026

Four Oregon Republicans faced off in a debate last month, each pushing their vision for the state’s future. The event in Hillsboro brought together candidates with different backgrounds—including business owners, a former athlete, and lawmakers. To join the discussion, hopefuls needed support from a

environment

Gold Rush Gone Wrong in the Amazon

April 18, 2026

For years, the Kichwa Indigenous community in Ecuador’s Napo province lived quietly along the Napo River. But now, their peaceful life has been disrupted by a new kind of invasion—not soldiers or settlers, but illegal gold miners tearing through their land. The miners aren’t just digging for treasur

technology

AI steps into science labs to speed up drug research

April 18, 2026

OpenAI’s newest AI model, named after DNA pioneer Rosalind Franklin, isn’t built to write poems or plan dinner menus. Instead, it’s trained to dig through mountains of scientific data to help researchers find new medicines faster. Drug development usually takes over a decade, but this tool could cut

technology

Two top researchers leave OpenAI as focus shifts to business AI tools

April 18, 2026

OpenAI’s latest shake-up shows the company is doubling down on money-making AI rather than flashy research projects. Kevin Weil and Bill Peebles, key figures behind some of OpenAI’s most ambitious but costly ventures, have recently stepped away. Weil previously led efforts to push science forward us

politics

Poland’s crypto debate: money, politics, and outside influences

April 18, 2026

Poland’s current government has accused a Warsaw-based crypto exchange of quietly bankrolling nationalist politicians and events tied to Russia. In a recent speech to lawmakers, Prime Minister Donald Tusk said the company, Zondacrypto, used cash linked to Russian mafia and intelligence networks to s

health

Peptides on the Table: FDA Steps In on Custom Drug Mixes

April 18, 2026

The U. S. health watchdog is about to check if some lab-made peptides can be mixed freely in pharmacies. Peptides—tiny protein pieces—are popping up in treatments for everything from sleep troubles to weight loss. Yet most of these mixes skip the usual safety checks. A panel will meet in late July

politics

How Iran’s War Could Freeze Climate Aid for Poor Nations

April 18, 2026

A fresh battle in the Persian Gulf isn’t just shaking up oil markets—it’s threatening the fragile promises rich countries made to help poorer nations fight climate change. Every dollar spent on war is one less dollar earmarked for solar panels, flood barriers, and clean-energy grids in places that d